Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.45 - $0.86 $2,384 - $4,556
5,298 Added 60.49%
14,057 $7,000
Q3 2022

Nov 10, 2022

SELL
$0.46 - $0.63 $3,307 - $4,529
-7,190 Reduced 45.08%
8,759 $4,000
Q2 2022

Aug 15, 2022

BUY
$0.47 - $0.87 $3,198 - $5,920
6,805 Added 74.42%
15,949 $9,000
Q1 2022

May 12, 2022

SELL
$0.75 - $1.77 $10,488 - $24,753
-13,985 Reduced 60.47%
9,144 $7,000
Q4 2021

Feb 14, 2022

BUY
$1.56 - $2.93 $21,467 - $40,319
13,761 Added 146.89%
23,129 $38,000
Q3 2021

Nov 15, 2021

SELL
$2.91 - $4.83 $51,390 - $85,297
-17,660 Reduced 65.34%
9,368 $29,000
Q2 2021

Aug 16, 2021

BUY
$4.17 - $5.74 $73,554 - $101,247
17,639 Added 187.87%
27,028 $126,000
Q1 2021

May 17, 2021

SELL
$5.28 - $9.64 $232 - $424
-44 Reduced 0.47%
9,389 $50,000
Q4 2020

Feb 16, 2021

SELL
$5.75 - $7.13 $192,970 - $239,282
-33,560 Reduced 78.06%
9,433 $62,000
Q3 2020

Nov 16, 2020

BUY
$4.9 - $7.12 $144,177 - $209,498
29,424 Added 216.85%
42,993 $263,000
Q2 2020

Aug 13, 2020

BUY
$6.43 - $9.86 $87,248 - $133,790
13,569 New
13,569 $98,000
Q4 2019

Feb 07, 2020

SELL
$8.49 - $12.81 $33,620 - $50,727
-3,960 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$5.58 - $14.47 $16,740 - $43,410
3,000 Added 312.5%
3,960 $45,000
Q2 2019

Aug 13, 2019

SELL
$5.22 - $9.08 $65,557 - $114,035
-12,559 Reduced 92.9%
960 $6,000
Q1 2019

May 14, 2019

BUY
$5.35 - $9.82 $72,326 - $132,756
13,519 New
13,519 $107,000
Q4 2018

Feb 14, 2019

SELL
$3.43 - $6.19 $21,266 - $38,378
-6,200 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$4.75 - $14.5 $16,411 - $50,097
3,455 Added 125.87%
6,200 $29,000
Q2 2018

Aug 15, 2018

BUY
$13.3 - $17.45 $36,508 - $47,900
2,745 New
2,745 $37,000
Q4 2017

Feb 09, 2018

SELL
$19.9 - $29.25 $60,535 - $88,978
-3,042 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.1 - $19.25 $45,934 - $58,558
3,042
3,042 $56,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.